The novelSLCO2A1heterozygous missense mutation p.E427K and nonsense mutation p.R603* in a female patient with pachydermoperiostosis with an atypical phenotype
- 19 May 2014
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 170 (5) , 1187-1189
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Mutations in theSLCO2A1Gene and Primary Hypertrophic Osteoarthropathy: A Clinical and Biochemical CharacterizationThe Journal of Clinical Endocrinology & Metabolism, 2013
- Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype–genotype correlation in Japanese patients with pachydermoperiostosisJournal of Dermatological Science, 2012
- Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosisHuman Mutation, 2012
- Mutations in the prostaglandin transporter encoding geneSLCO2A1Cause primary hypertrophic osteoarthropathy and isolated digital clubbingHuman Mutation, 2012
- Sex hormones induce a gender-related difference in renal expression of a novel prostaglandin transporter, OAT-PG, influencing basal PGE2concentrationAmerican Journal of Physiology-Renal Physiology, 2012
- Exome Sequencing Identifies SLCO2A1 Mutations as a Cause of Primary Hypertrophic OsteoarthropathyThe American Journal of Human Genetics, 2012
- Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathyNature Genetics, 2008
- Pachydermoperiostosis: an updateClinical Genetics, 2005
- Estrogen suppresses IL-1β-mediated induction of COX-2 pathway in rat cerebral blood vesselsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004